Chemcrux Enterprises Limited (BOM:540395)

Market Cap	1.37B -38.6%
Revenue (ttm)	727.43M -0.1%
Net Income	20.85M -62.9%
EPS	1.41 -62.9%
Shares Out	14.81M
PE Ratio	65.71
Forward PE	n/a
Dividend	1.00 (1.07%)
Ex-Dividend Date	Sep 17, 2025

Volume	3,715
Average Volume	9,743
Open	93.95
Previous Close	91.67
Day's Range	90.30 - 93.95
52-Week Range	64.00 - 158.60
Beta	0.34
RSI	56.01
Earnings Date	May 14, 2026

About Chemcrux Enterprises

Chemcrux Enterprises Limited engages in the manufacture and sale of intermediates and chemicals in India. Its chemicals and intermediates products are used in the manufacture of bulk drugs active pharmaceutical ingredients, electro-plating, pharmaceuticals, dyes, and pigments. The company offers chloro benzoic acid, nitro benzoic acid, nitro salicylic, dichloro benzoic acid, chloro nitro benzoic acid, lasamide, arabonic acid sodium salt, chloro benzoic acid sulfonamide, BPEA sulfonamide, para and ortho chloro benzoyl chloride, and chloro benzoy...

• Industry: Chemicals and Allied Products
• Founded: 1983
• Employees: 102
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 540395

Financial Performance

In fiscal year 2025, Chemcrux Enterprises's revenue was 706.67 million, a decrease of -10.34% compared to the previous year's 788.19 million. Earnings were 39.13 million, a decrease of -53.66%.